Maksymowych WP - Search Results

1

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.

Maksymowych WP, van der Heijde D, Baraliakos X, Deodhar A, Sherlock SP, Li D, Fleishaker D, Hendrikx T, Kanik KS. Maksymowych WP, et al. Rheumatology (Oxford). 2018 Aug 1;57(8):1390-1399. doi: 10.1093/rheumatology/key104. Rheumatology (Oxford). 2018. PMID: 29718421 Free PMC article. Clinical Trial.

2

Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity.

Maksymowych WP, Adlam N, Lind D, Russell AS. Maksymowych WP, et al. Clin Rheumatol. 1997 Sep;16(5):461-5. doi: 10.1007/BF02238938. Clin Rheumatol. 1997. PMID: 9348140 Clinical Trial.

3

An open study of pamidronate in the treatment of refractory ankylosing spondylitis.

Maksymowych WP, Jhangri GS, Leclercq S, Skeith K, Yan A, Russell AS. Maksymowych WP, et al. J Rheumatol. 1998 Apr;25(4):714-7. J Rheumatol. 1998. PMID: 9558174 Clinical Trial.

4

Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.

Vaile JH, Meddings JB, Yacyshyn BR, Russell AS, Maksymowych WP. Vaile JH, et al. Among authors: maksymowych wp. J Rheumatol. 1999 Jan;26(1):128-35. J Rheumatol. 1999. PMID: 9918253

5

LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.

Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. Maksymowych WP, et al. J Rheumatol. 2000 Jan;27(1):183-9. J Rheumatol. 2000. PMID: 10648037

6

Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

Maksymowych WP, Lambert R, Jhangri GS, Leclercq S, Chiu P, Wong B, Aaron S, Russell AS. Maksymowych WP, et al. J Rheumatol. 2001 Jan;28(1):144-55. J Rheumatol. 2001. PMID: 11196517 Clinical Trial.

7

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.

Maksymowych WP, Jhangri GS, Lambert RG, Mallon C, Buenviaje H, Pedrycz E, Luongo R, Russell AS. Maksymowych WP, et al. J Rheumatol. 2002 May;29(5):959-65. J Rheumatol. 2002. PMID: 12022358 Clinical Trial.

8

Ankylosing spondylitis and current disease-controlling agents: do they work?

Maksymowych WP, Breban M, Braun J. Maksymowych WP, et al. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):619-30. Best Pract Res Clin Rheumatol. 2002. PMID: 12406430 Review.

9

Therapy for ankylosing spondylitis: new treatment modalities.

Braun J, Breban M, Maksymowych WP. Braun J, et al. Among authors: maksymowych wp. Best Pract Res Clin Rheumatol. 2002 Sep;16(4):631-51. Best Pract Res Clin Rheumatol. 2002. PMID: 12406431 Review.

10

The dosage of infliximab in the treatment of ankylosing spondylitis: dollars and sense.

Russell AS, Orozco JH, Maksymowych WP. Russell AS, et al. Among authors: maksymowych wp. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S135-6. Clin Exp Rheumatol. 2002. PMID: 12463464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters